Simtra BioPharma Solutions Makes Investment in Right to Work Indiana

Simtra BioPharma Solutions is investing $250 million in order to expand in Right to Work Bloomington, Indiana. As a result, they will create 130 new jobs!

From Area Development Magazine:

“We are experiencing a broad increase in demand and need for injectable manufacturing in therapeutic classes such as GLP-1 drugs and product categories such Antibody-Drug-Conjugates as well as overall continued growth of the oncology pipeline. […] Our customers consider our sites in Halle and Bloomington as an extension of their manufacturing network, so we are thrilled to further enhance our capabilities and resources to help them meet their respective goals. This expansion is the latest in a series of strategic, long-term investments to ensure that Simtra continues to grow with and for our customers.” […]

“Indiana is a growing life sciences leader, advancing critical R&D and delivering life-changing pharmaceuticals and solutions for people around the world. […] Simtra is an important part of this ecosystem, and the company’s expansion will catalyze quality job opportunities, economic growth, and industry momentum for years to come.” […]

“Simtra’s expansion with this project represents a significant win for Monroe County’s economic landscape. […] This investment not only creates high-quality jobs but also reinforces our community’s reputation as a hub for innovation and growth in the biopharmaceutical industry. We are proud to support Simtra in their endeavors, grateful to Monroe County and the state for their support of the expansion, and look forward to the continued success of this partnership.”

AREA DEVELOPMENT MAGAZINE

To read the previous economic update on Right to Work states, click here.